Assays for cyclin-dependent kinase inhibitors.
Senderowicz
Adrian M
AM
Molecular Therapeutics Unit, Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
D000818:Animals; D001681:Biological Assay / Q000379:methods*; D015153:Blotting, Western; D001973:Bromodeoxyuridine / Q000378:metabolism; D002478:Cells, Cultured; D018844:Cyclin-Dependent Kinases / Q000032:analysis* / Q000037:antagonists & inhibitors*; D004791:Enzyme Inhibitors / Q000032:analysis*; D005434:Flow Cytometry; D006801:Humans; D008856:Microscopy, Fluorescence; D011233:Precipitin Tests / Q000379:methods; D016196:S Phase; D013379:Substrate Specificity
D004791:Enzyme Inhibitors; D018844:Cyclin-Dependent Kinases; D001973:Bromodeoxyuridine